| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8271999 | Journal of Geriatric Oncology | 2018 | 6 Pages |
Abstract
The current data suggest that fit older patients with mCRC can be safely treated with a cetuximab-based therapy, as QoL and safety profile do not seem to be affected by age. In addition, age did not impact the choice of chemotherapy to be associated to cetuximab and treatment compliance.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Gerardo Rosati, Carmine Pinto, Francesca Di Fabio, Silvana Chiara, Ivan R. Lolli, Enzo M. Ruggeri, Libero Ciuffreda, Raimondo Ferrara, Lorenzo Antonuzzo, Daniela Adua, Patrizia Racca, Domenico Bilancia, Elena Benincasa, Maria Elena Stroppolo,